-
-
-
-
-
-
-
Odyssey Health (ODYY) Provides Update on Asset Purchase Agreement with Oragenics (OGEN)
-
-
-
-
-
-
-
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
-
-
-
-
-
-
-
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
-
-
-
-
-
-
-
IBN (InvestorBrandNetwork) Announces Latest Episode of The Stock2Me Podcast featuring Two-Time Olympic Gold Medalist Abby Wambach on Behalf of Odyssey Health Inc.
-
-
-
-
-
-
-
NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION
-
-
-
-
-
-
-
Odyssey Group International and Super Bowl MVPs Featured on “Banfield” Discussed Novel Concussion Treatment
-
-
-
-
-
-
-
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
-
1,157,734 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

